Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes
Clinical trial NCT03005288 · COMPLETED
Trial details
- NCT number
- NCT03005288
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2019-03-21
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.